Risk factors for intracerebral hemorrhage: The reasons for geographic and racial differences in stroke (REGARDS) study

Stroke

Volumn 44, Issue 5, 2013, Pages 1282-1287

  Howard, George ^a   Cushman, Mary ^b   Howard, Virginia J ^a   Kissela, Brett M ^c   Kleindorfer, Dawn O ^c   Moy, Claudia S ^d   Switzer, Jeffery ^e   Woo, Daniel ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

black race; hypertension; intracerebral hemorrhage; risk factors

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ADULT; ARTICLE; BRAIN HEMORRHAGE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 84876878890     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000529     Document Type: Article

References (20)

1. Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracere-bral hemorrhage in the general population: a systematic review. Stroke. 2003;34:2060-2065.
2. Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szafarski J P, Gebel J, et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke. 2002;33:1190-1195.
3. Feldmann E, Broderick JP, Kernan WN, Viscoli CM, Brass LM, Brott T, et al. Major risk factors for intracerebral hemorrhage in the young are modifable. Stroke. 2005;36:1881-1885.
4. Sturgeon JD, Folsom AR, Longstreth WT Jr, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007;38:2718-2725.
5. Broderick JP, Brott T, Tomsick T, Huster G, Miller R. The risk of sub-arachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 1992;326:733-736.
6. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350, 977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320:904-910.
7. Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez P, Lechat P. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Intern Med. 2003;163:669-676.
8. Amarenco P, Bogousslavsky J, Callahan A III, Goldstein LB, Hennerici M, Rudolph AE, et al; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559.
9. McKinney JS, Kostis WJ. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke. 2012;43:2149-2156.
10. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25:135-143.
11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular fltration rate. Ann Intern Med. 2009;150:604-612.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
13. Howard VJ, Kleindorfer DO, Judd SE, McClure LA, Safford MM, Rhodes JD, et al. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol. 2011;69:619-627.
14. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: J. Wiley & Sons; 1987.
15. Howard G, McClure LA, Moy CS, Safford MM, Cushman M, Judd SE, et al. Imputation of incident events in longitudinal cohort studies. Am J Epidemiol. 2011;174:718-726.
16. Howard G, Cushman M, Kissela BM, Kleindorfer DO, McClure LA, Safford MM, et al; REasons for Geographic And Racial Differences in Stroke (REGARDS) Investigators. Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke. 2011;42:3369-3375.
17. Woo D, Haverbusch M, Sekar P, Kissela B, Khoury J, Schneider A, et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke. 2004;35:1703-1708.
18. van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fbrillation: an individual patient meta-analysis. J Am Med Assoc. 2002;288:2441-2448.
19. Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, et al; WARCEF Investigators. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366:1859-1869.
20. National Institute on Alcohol Abuse and Alcoholism. The Physicians' Guide to Helping Patients With Alcohol Problems (Revised). Bethesda, MD: NIAAA; 2004.